Effect of a Novel Indole-3-derivate Indirubin on Human HepG2 Cells and Underlying Mechanism

TAN De-fei,GUO Wen-jie,XIA Juan,GUAN Ting-wei,GAO Jing,YAO Qi-zheng
DOI: https://doi.org/10.13312/j.issn.1671-7783.y140246
2015-01-01
Abstract:Objective:To investigate the anti-tumor effects and possible mechanisms of a novel indole-3-derivate indirubin in vitro.Methods:Human HepG2 cells were exposed to different concentrations of indole-3-derivate A,cell proliferation was detected by MTT assay and cell colony formation of HepG2 cells treated with indole-3-derivate A was also observed.Then the nuclei changes were observed by staining with DAPI and cell apoptosis was detected by Annexin-V/PI staining.Meanwhile,mitochondrial membrane potential and intracellular free Ca2+ content were detected with JC-1and Fluo-3/AM staining,respectively.Moreover,the protein levels of Bcl-2,Bax and activation of Caspase-3,9 were examined by western blotting.Results:Indole-3-derivate A inhibited the proliferation and colony formation of HepG2 cells in a doseand time-dependent way.Besides that,it was found that nucleus morphology was showing pyknosis and fragmentation and early apoptotic cells were significantly increased by Annexin-V/PI staining after indole-3-derivate A treatment.Moreover,western blotting showed indole-3-derivate A activated Caspase-3,9,decreased the expression of Bcl-2 and increased the expression of Bax in a dose-dependent manner.In addition,indole-3-derivate A caused a loss of mitochondrial membrane potential and intracellular Ca2+ overloading.Conclusions:Indole-3-derivate A could significantly inhibit proliferation of HepG2 cells and the mechanisms might be related to mitochondria dysfunction and activation of mitochondria-dependent apoptotic pathway.
What problem does this paper attempt to address?